Carnitine Palmitoyltransferase 1A (CPT1A): a Transcriptional Target of PAX3-FKHR and Mediates PAX3-FKHR-dependent Motility in Alveolar Rhabdomyosarcoma Cells

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2012 Apr 27

PMID 22533991

Citations 30

Authors

Lingling Liu

Yong-Dong Wang

Jing Wu

Jimmy Cui

Taosheng Chen

Affiliations

Soon will be listed here.

Abstract

Background: Alveolar rhabdomyosarcoma (ARMS) has a high propensity to metastasize, leading to its aggressiveness and a poor survival rate among those with the disease. More than 80% of aggressive ARMSs harbor a PAX3-FKHR fusion transcription factor, which regulates cell migration and promotes metastasis, most likely by regulating the fusion protein's transcriptional targets. Therefore, identifying druggable transcription targets of PAX3-FKHR that are also downstream effectors of PAX3-FKHR-mediated cell migration and metastasis may lead to novel therapeutic approaches for treating ARMS.

Methods: To identify genes whose expression is directly affected by the level of PAX3-FKHR in an ARMS cellular-context, we first developed an ARMS cell line in which PAX3-FKHR is stably down-regulated, and showed that stably downregulating PAX3-FKHR in ARMS cells significantly decreased the cells' motility. We used microarray analysis to identify genes whose expression level decreased when PAX3-FKHR was downregulated. We used mutational analysis, promoter reporter assays, and electrophoretic mobility shift assays to determine whether PAX3-FKHR binds to the promoter region of the target gene. We used siRNA and pharmacologic inhibitor to downregulate the target gene of PAX3-FKHR and investigated the effect of such downregulation on cell motility.

Results: We found that when PAX3-FKHR was downregulated, the expression of carnitine palmitoyltransferase 1A (CPT1A) decreased. We showed that PAX3-FKHR binds to a paired-domain binding-site in the CPT1A promoter region, indicating that CPT1A is a novel transcriptional target of PAX3-FKHR. Furthermore, downregulating CPT1A decreased cell motility in ARMS cells, indicating that CPT1A is a downstream effector of PAX3-FKHR-mediated cell migration and metastasis.

Conclusions: Taken together, we have identified CPT1A as a novel transcriptional target of PAX3-FKHR and revealed the novel function of CPT1A in promoting cell motility. CPT1A may represent a novel therapeutic target for the treatment of ARMS.

Citing Articles

Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification.

Talapatra J, Reddy M Cancers (Basel). 2023; 15(7).

PMID: 37046804 PMC: 10093342. DOI: 10.3390/cancers15072144.

Alfalfa Xeno-miR168b Target to Regulate Milk Fat Synthesis in Bovine Mammary Epithelial Cells.

Jia J, Duan H, Liu B, Ma Y, Ma Y, Cai X Metabolites. 2023; 13(1).

PMID: 36677001 PMC: 9866016. DOI: 10.3390/metabo13010076.

Inhibition of lipid metabolism exerts antitumor effects on rhabdomyosarcoma.

Miyagaki S, Kikuchi K, Mori J, Lopaschuk G, Iehara T, Hosoi H Cancer Med. 2021; 10(18):6442-6455.

PMID: 34472721 PMC: 8446407. DOI: 10.1002/cam4.4185.

Nanotechnology-Based Strategies to Evaluate and Counteract Cancer Metastasis and Neoangiogenesis.

Sen O, Emanet M, Ciofani G Adv Healthc Mater. 2021; 10(10):e2002163.

PMID: 33763992 PMC: 7610913. DOI: 10.1002/adhm.202002163.

ACTA1 is inhibited by PAX3-FOXO1 through RhoA-MKL1-SRF signaling pathway and impairs cell proliferation, migration and tumor growth in Alveolar Rhabdomyosarcoma.

Hu Q, Zhu L, Li Y, Zhou J, Xu J Cell Biosci. 2021; 11(1):25.

PMID: 33509264 PMC: 7842031. DOI: 10.1186/s13578-021-00534-3.

References

Linardic C . PAX3-FOXO1 fusion gene in rhabdomyosarcoma. Cancer Lett. 2008; 270(1):10-8. PMC: 2575376. DOI: 10.1016/j.canlet.2008.03.035. View

Yang D, Tao J, Li L, Kedei N, Toth Z, Czap A . RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanoma. Oncogene. 2011; 30(45):4590-4600. PMC: 3951887. DOI: 10.1038/onc.2011.166. View

Zhang L, Wang C . Identification of a new class of PAX3-FKHR target promoters: a role of the Pax3 paired box DNA binding domain. Oncogene. 2006; 26(11):1595-605. PMC: 2238811. DOI: 10.1038/sj.onc.1209958. View

Kikuchi K, Tsuchiya K, Otabe O, Gotoh T, Tamura S, Katsumi Y . Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma. Biochem Biophys Res Commun. 2007; 365(3):568-74. DOI: 10.1016/j.bbrc.2007.11.017. View

Wolfgang M, Cha S, Millington D, Cline G, Shulman G, Suwa A . Brain-specific carnitine palmitoyl-transferase-1c: role in CNS fatty acid metabolism, food intake, and body weight. J Neurochem. 2008; 105(4):1550-9. PMC: 3888516. DOI: 10.1111/j.1471-4159.2008.05255.x. View

Libura J, Drukala J, Majka M, Tomescu O, Navenot J, Kucia M . CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood. 2002; 100(7):2597-606. DOI: 10.1182/blood-2002-01-0031. View

Lim S, Orhant-Prioux M, Toy W, Tan K, Lim Y . Tyrosine phosphorylation of transcriptional coactivator WW-domain binding protein 2 regulates estrogen receptor α function in breast cancer via the Wnt pathway. FASEB J. 2011; 25(9):3004-18. DOI: 10.1096/fj.10-169136. View

Mercado G, Barr F . Fusions involving PAX and FOX genes in the molecular pathogenesis of alveolar rhabdomyosarcoma: recent advances. Curr Mol Med. 2007; 7(1):47-61. DOI: 10.2174/156652407779940440. View

Oudin M, Gajendra S, Williams G, Hobbs C, Lalli G, Doherty P . Endocannabinoids regulate the migration of subventricular zone-derived neuroblasts in the postnatal brain. J Neurosci. 2011; 31(11):4000-11. PMC: 6623539. DOI: 10.1523/JNEUROSCI.5483-10.2011. View

10.

Hernlund E, Ihrlund L, Khan O, Ates Y, Linder S, Panaretakis T . Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir. Int J Cancer. 2008; 123(2):476-483. DOI: 10.1002/ijc.23525. View

11.

Xia S, Barr F . Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein. Oncogene. 2004; 23(41):6864-71. DOI: 10.1038/sj.onc.1207850. View

12.

Zeng F, Dong H, Cui J, Liu L, Chen T . Glycogen synthase kinase 3 regulates PAX3-FKHR-mediated cell proliferation in human alveolar rhabdomyosarcoma cells. Biochem Biophys Res Commun. 2009; 391(1):1049-55. PMC: 2812657. DOI: 10.1016/j.bbrc.2009.12.017. View

13.

Lee K, Kerner J, Hoppel C . Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex. J Biol Chem. 2011; 286(29):25655-62. PMC: 3138250. DOI: 10.1074/jbc.M111.228692. View

14.

Wan J, Jiang L, Lu Q, Ke L, Li X, Tong N . Activation of PPARdelta up-regulates fatty acid oxidation and energy uncoupling genes of mitochondria and reduces palmitate-induced apoptosis in pancreatic beta-cells. Biochem Biophys Res Commun. 2009; 391(3):1567-72. DOI: 10.1016/j.bbrc.2009.12.127. View

15.

Nyman L, Cox K, Hoppel C, Kerner J, Barnoski B, Hamm D . Homozygous carnitine palmitoyltransferase 1a (liver isoform) deficiency is lethal in the mouse. Mol Genet Metab. 2005; 86(1-2):179-87. DOI: 10.1016/j.ymgme.2005.07.021. View

16.

Schreurs M, Kuipers F, van der Leij F . Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome. Obes Rev. 2009; 11(5):380-8. DOI: 10.1111/j.1467-789X.2009.00642.x. View

17.

Lin H, Lu J, Laflamme P, Qiao S, Shayegan B, Bryskin I . Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: a mechanistic model supporting prevention strategies. Int J Oncol. 2010; 37(4):761-6. DOI: 10.3892/ijo_00000725. View

18.

Zaugg K, Yao Y, Reilly P, Kannan K, Kiarash R, Mason J . Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev. 2011; 25(10):1041-51. PMC: 3093120. DOI: 10.1101/gad.1987211. View

19.

Pondugula S, Tong A, Wu J, Cui J, Chen T . Protein phosphatase 2Cbetal regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells. Drug Metab Dispos. 2010; 38(9):1411-6. PMC: 2939471. DOI: 10.1124/dmd.110.032128. View

20.

Zeng F, Cui J, Liu L, Chen T . PAX3-FKHR sensitizes human alveolar rhabdomyosarcoma cells to camptothecin-mediated growth inhibition and apoptosis. Cancer Lett. 2009; 284(2):157-64. PMC: 2739888. DOI: 10.1016/j.canlet.2009.04.016. View